Can intranasal delivery of dexamethasone facilitate the management of severe altitude disease?
Journal of Travel Medicine · 2023
DOI: 10.1093/jtm/taad026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Travel Medicine, 2023. Verfasst von Robert K Szymczak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Faculty of Health Sciences, Medical University of Gdańsk, Mariana Smoluchowskiego 17, Gdańsk 80-214, Poland. Hauptthemen laut MEDLINE: Altitude Sickness, Mountaineering. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Faculty of Health Sciences, Medical University of Gdańsk, Mariana Smoluchowskiego 17, Gdańsk 80-214, Poland.
- Department of Neurology, Faculty of Medicine, Medical University of Gdańsk, Mariana Smoluchowskiego 17, Gdańsk 80-214, Poland.
ORCID-Profile: Robert K Szymczak, Magdalena Sawicka
Zitieren
APA
Szymczak, R. K., & Sawicka, M. (2023). Can intranasal delivery of dexamethasone facilitate the management of severe altitude disease?. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taad026
Vancouver
Szymczak RK, Sawicka M. Can intranasal delivery of dexamethasone facilitate the management of severe altitude disease?. Journal of Travel Medicine. 2023. doi:10.1093/jtm/taad026
BibTeX
@article{Szymczak2023,
author = {Szymczak, Robert K and Sawicka, Magdalena},
title = {Can intranasal delivery of dexamethasone facilitate the management of severe altitude disease?},
journal = {Journal of Travel Medicine},
year = {2023},
doi = {10.1093/jtm/taad026}
}
EUVIMED